Works matching AU Renouf, Daniel J.

Results: 59
    1
    2
    3

    Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.

    Published in:
    Nature Medicine, 2015, v. 21, n. 11, p. 1364, doi. 10.1038/nm.3973
    By:
    • Huang, Ling;
    • Holtzinger, Audrey;
    • Jagan, Ishaan;
    • BeGora, Michael;
    • Lohse, Ines;
    • Ngai, Nicholas;
    • Nostro, Cristina;
    • Wang, Rennian;
    • Muthuswamy, Lakshmi B;
    • Crawford, Howard C;
    • Arrowsmith, Cheryl;
    • Kalloger, Steve E;
    • Renouf, Daniel J;
    • Connor, Ashton A;
    • Cleary, Sean;
    • Schaeffer, David F;
    • Roehrl, Michael;
    • Tsao, Ming-Sound;
    • Gallinger, Steven;
    • Keller, Gordon
    Publication type:
    Article
    4
    5
    6

    Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03593-2
    By:
    • Baginska, Joanna;
    • Nau, Allison;
    • Gomez Diaz, Ilana;
    • Giobbie-Hurder, Anita;
    • Weirather, Jason;
    • Vergara, Juliana;
    • Abrecht, Charlotte;
    • Hallisey, Margaret;
    • Dennis, Jenna;
    • Severgnini, Mariano;
    • Huezo, Julia;
    • Marciello, Isabella;
    • Rahma, Osama;
    • Manos, Michael;
    • Brohl, Andrew S.;
    • Bedard, Philippe L.;
    • Renouf, Daniel J.;
    • Sharon, Elad;
    • Streicher, Howard;
    • Ott, Patrick A.
    Publication type:
    Article
    7
    8

    Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.

    Published in:
    Carcinogenesis, 2015, v. 36, n. 9, p. 956, doi. 10.1093/carcin/bgv073
    By:
    • Eng, Lawson;
    • Azad, Abul Kalam;
    • Xin Qiu;
    • Qin Quinn Kong;
    • Dangxiao Cheng;
    • Nanjiao Ying;
    • Tse, Alvina;
    • Qin Kuang;
    • Dodbiba, Lorin;
    • Renouf, Daniel J.;
    • Marsh, Sharon;
    • Savas, Sevtap;
    • Mackay, Helen J.;
    • Knox, Jennifer J.;
    • Darling, Gail E.;
    • Wong, Rebecca K. S.;
    • Wei Xu;
    • Liu, Geoffrey;
    • Faluyi, Olusola O.
    Publication type:
    Article
    9

    Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31199-2
    By:
    • Hilton, John;
    • Gelmon, Karen;
    • Bedard, Philippe L.;
    • Tu, Dongsheng;
    • Xu, Hong;
    • Tinker, Anna V.;
    • Goodwin, Rachel;
    • Laurie, Scott A.;
    • Jonker, Derek;
    • Hansen, Aaron R.;
    • Veitch, Zachary W.;
    • Renouf, Daniel J.;
    • Hagerman, Linda;
    • Lui, Hongbo;
    • Chen, Bingshu;
    • Kellar, Deb;
    • Li, Irene;
    • Lee, Sung-Eun;
    • Kono, Takako;
    • Cheng, Brian Y. C.
    Publication type:
    Article
    10
    11
    12

    The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32591-8
    By:
    • Renouf, Daniel J.;
    • Loree, Jonathan M.;
    • Knox, Jennifer J.;
    • Topham, James T.;
    • Kavan, Petr;
    • Jonker, Derek;
    • Welch, Stephen;
    • Couture, Felix;
    • Lemay, Frederic;
    • Tehfe, Mustapha;
    • Harb, Mohammed;
    • Aucoin, Nathalie;
    • Ko, Yoo-Joung;
    • Tang, Patricia A.;
    • Ramjeesingh, Ravi;
    • Meyers, Brandon M.;
    • Kim, Christina A.;
    • Du, Pan;
    • Jia, Shidong;
    • Schaeffer, David F.
    Publication type:
    Article
    13
    14

    Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183682
    By:
    • Boutin, Mélina;
    • Topham, James T.;
    • Feilotter, Harriet;
    • Kennecke, Hagen F.;
    • Couture, Félix;
    • Harb, Mohammed;
    • Kavan, Peter;
    • Berry, Scott;
    • Lim, Howard J.;
    • Goffin, John R.;
    • Ahmad, Chaudhary;
    • Lott, Anthony;
    • Renouf, Daniel J.;
    • Jonker, Derek J.;
    • Tu, Dongsheng;
    • O'Callaghan, Chris J.;
    • Chen, Eric X.;
    • Loree, Jonathan M.
    Publication type:
    Article
    15
    16
    17

    Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-021-02236-7
    By:
    • Voon, Pei Jye;
    • Chen, Eric X.;
    • Chen, Helen X.;
    • Lockhart, Albert C.;
    • Sahebjam, Solmaz;
    • Kelly, Karen;
    • Vaishampayan, Ulka N.;
    • Subbiah, Vivek;
    • Razak, Albiruni R.;
    • Renouf, Daniel J.;
    • Hotte, Sebastien J.;
    • Singh, Arti;
    • Bedard, Philippe L.;
    • Hansen, Aaron R.;
    • Ivy, S. Percy;
    • Wang, Lisa;
    • Stayner, Lee-Anne;
    • Siu, Lillian L.;
    • Spreafico, Anna
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 7, doi. 10.1634/theoncologist.2020-0379
    By:
    • Cadranel, Jacques;
    • Liu, Stephen V.;
    • Duruisseaux, Michaël;
    • Branden, Eva;
    • Goto, Yasushi;
    • Weinberg, Benjamin A.;
    • Heining, Christoph;
    • Schlenk, Richard F.;
    • Cheema, Parneet;
    • Jones, Martin R.;
    • Drilon, Alexander;
    • Trombetta, Domenico;
    • Muscarella, Lucia Anna;
    • Tolba, Khaled;
    • Gounant, Valerie;
    • Cseh, Agnieszka;
    • Solca, Flavio;
    • Laskin, Janessa J.;
    • Renouf, Daniel J.
    Publication type:
    Article
    25

    Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor.

    Published in:
    Oncologist, 2014, v. 19, n. 6, p. 623, doi. 10.1634/theoncologist.2013-0390
    By:
    • Jamshidi, Farzad;
    • Pleasance, Erin;
    • Li, Yvonne;
    • Shen, Yaoqing;
    • Kasaian, Katayoon;
    • Corbett, Richard;
    • Eirew, Peter;
    • Lum, Amy;
    • Pandoh, Pawan;
    • Zhao, Yongjun;
    • Schein, Jacqueline E.;
    • Moore, Richard A.;
    • Rassekh, Rod;
    • Huntsman, David G.;
    • Knowling, Meg;
    • Lim, Howard;
    • Renouf, Daniel J.;
    • Jones, Steven J.M.;
    • Marra, Marco A.;
    • Nielsen, Torsten O.
    Publication type:
    Article
    26

    Clinical and cost outcomes following genomics‐informed treatment for advanced cancers.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 15, p. 5131, doi. 10.1002/cam4.4076
    By:
    • Weymann, Deirdre;
    • Pollard, Samantha;
    • Chan, Brandon;
    • Titmuss, Emma;
    • Bohm, Alexandra;
    • Laskin, Janessa;
    • Jones, Steven J. M.;
    • Pleasance, Erin;
    • Nelson, Jessica;
    • Fok, Alexandra;
    • Lim, Howard;
    • Karsan, Aly;
    • Renouf, Daniel J.;
    • Schrader, Kasmintan A.;
    • Sun, Sophie;
    • Yip, Stephen;
    • Schaeffer, David F.;
    • Marra, Marco A.;
    • Regier, Dean A.
    Publication type:
    Article
    27
    28

    Validation of micro RNA pathway polymorphisms in esophageal adenocarcinoma survival.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 2, p. 361, doi. 10.1002/cam4.989
    By:
    • Faluyi, Olusola O.;
    • Eng, Lawson;
    • Qiu, Xin;
    • Che, Jiahua;
    • Zhang, Qihuang;
    • Cheng, Dangxiao;
    • Ying, Nanjiao;
    • Tse, Alvina;
    • Kuang, Qin;
    • Dodbiba, Lorin;
    • Renouf, Daniel J.;
    • Marsh, Sharon;
    • Savas, Sevtap;
    • Mackay, Helen J.;
    • Knox, Jennifer J.;
    • Darling, Gail E.;
    • Wong, Rebecca K. S.;
    • Xu, Wei;
    • Azad, Abul Kalam;
    • Liu, Geoffrey
    Publication type:
    Article
    29
    30
    31
    32

    Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00368-x
    By:
    • Tsang, Erica S.;
    • Csizmok, Veronika;
    • Williamson, Laura M.;
    • Pleasance, Erin;
    • Topham, James T.;
    • Karasinska, Joanna M.;
    • Titmuss, Emma;
    • Schrader, Intan;
    • Yip, Stephen;
    • Tessier-Cloutier, Basile;
    • Mungall, Karen;
    • Ng, Tony;
    • Sun, Sophie;
    • Lim, Howard J.;
    • Loree, Jonathan M.;
    • Laskin, Janessa;
    • Marra, Marco A.;
    • Jones, Steven J. M.;
    • Schaeffer, David F.;
    • Renouf, Daniel J.
    Publication type:
    Article
    33

    Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00238-4
    By:
    • Williamson, Laura M.;
    • Rive, Craig M.;
    • Di Francesco, Daniela;
    • Titmuss, Emma;
    • Chun, Hye-Jung E.;
    • Brown, Scott D.;
    • Milne, Katy;
    • Pleasance, Erin;
    • Lee, Anna F.;
    • Yip, Stephen;
    • Rosenbaum, Daniel G.;
    • Hasselblatt, Martin;
    • Johann, Pascal D.;
    • Kool, Marcel;
    • Harvey, Melissa;
    • Dix, David;
    • Renouf, Daniel J.;
    • Holt, Robert A.;
    • Nelson, Brad H.;
    • Hirst, Martin
    Publication type:
    Article
    34

    Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.

    Published in:
    NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0050-5
    By:
    • Thibodeau, My Linh;
    • Bonakdar, Melika;
    • Zhao, Eric;
    • Mungall, Karen L.;
    • Reisle, Caralyn;
    • Zhang, Wei;
    • Bye, Morgan H.;
    • Thiessen, Nina;
    • Bleile, Dustin;
    • Mungall, Andrew J.;
    • Ma, Yussanne P.;
    • Jones, Martin R.;
    • Renouf, Daniel J.;
    • Lim, Howard J.;
    • Yip, Stephen;
    • Ng, Tony;
    • Ho, Cheryl;
    • Laskin, Janessa;
    • Marra, Marco A.;
    • Schrader, Kasmintan A.
    Publication type:
    Article
    35

    Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles.

    Published in:
    Cancer & Metabolism, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40170-024-00357-z
    By:
    • Ali, Hassan A.;
    • Karasinska, Joanna M.;
    • Topham, James T.;
    • Johal, Danisha;
    • Kalloger, Steve;
    • Metcalfe, Andrew;
    • Warren, Cassia S.;
    • Miyagi, Anthony;
    • Tao, Lan V.;
    • Kevorkova, Maya;
    • Chafe, Shawn C.;
    • McDonald, Paul C.;
    • Dedhar, Shoukat;
    • Parker, Seth J.;
    • Renouf, Daniel J.;
    • Schaeffer, David F.
    Publication type:
    Article
    36

    A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.

    Published in:
    Journal of Pathology: Clinical Research, 2017, v. 3, n. 3, p. 179, doi. 10.1002/cjp2.75
    By:
    • Kalloger, Steve E;
    • Riazy, Maziar;
    • Tessier-Cloutier, Basile;
    • Karasinska, Joanna M;
    • Gao, Dongxia;
    • Peixoto, Renata D;
    • Samimi, Setareh;
    • Chow, Christine;
    • Wong, Hui-Li;
    • Mackey, John R;
    • Renouf, Daniel J;
    • Schaeffer, David F
    Publication type:
    Article
    37

    Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities.

    Published in:
    Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01401-9
    By:
    • Takemon, Yuka;
    • Pleasance, Erin D.;
    • Gagliardi, Alessia;
    • Hughes, Christopher S.;
    • Csizmok, Veronika;
    • Wee, Kathleen;
    • Trinh, Diane L.;
    • Huff, Ryan D.;
    • Mungall, Andrew J.;
    • Moore, Richard A.;
    • Chuah, Eric;
    • Mungall, Karen L.;
    • Lewis, Eleanor;
    • Nelson, Jessica;
    • Lim, Howard J.;
    • Renouf, Daniel J.;
    • Jones, Steven JM.;
    • Laskin, Janessa;
    • Marra, Marco A.
    Publication type:
    Article
    38

    Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251332154
    By:
    • Goss, Glenwood;
    • Ciuleanu, Tudor;
    • Ramlau, Rodryg;
    • Renouf, Daniel J.;
    • Chu, Quincy;
    • Kalinka, Ewa;
    • Sawrycki, Piotr;
    • Bramson, Jonathan;
    • Nelson, Brad H.;
    • Crabbé, Rafael;
    • LaCasse, Eric;
    • Lo, Bryan;
    • Sahlender, Daniela A.;
    • Crompton, Philippa;
    • Brichory, Franck;
    • Piggott, Luke;
    • Schenker, Michael;
    • Juergens, Rosalyn
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50